FDA.reportPublic FDA data

betamethasone valerate 1.2 MG/ML Topical Foam [Luxiq]

RxCUI
1244636
RxNorm name
betamethasone valerate 1.2 MG/ML Topical Foam [Luxiq]
Display name
LUXIQ (Topical)
Full name
betamethasone valerate 1.2 MG/ML Topical Foam [Luxiq]
Term type
SBD
Status
Active
Strength
0.12%
Dose form
Foam
Route
Topical
Updated
2026-09-09 14:39:08

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032012
Active start
032012
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
betamethasone valerate1.2 MG / 1 MLbetamethasonebetamethasone valerate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Foam346285

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
betamethasone1514

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRLuxiq 0.12 % Topical Foam1NAMES
RxNorm Namebetamethasone valerate 1.2 MG/ML Topical Foam [Luxiq]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
RxCUI12446361CODES
MMSL_CODEBD69251CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 21 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00378818701rxnav_ndcsyes
00378818750rxnav_ndcsyes
00145002100rxnav_historical
00145002112rxnav_historical
00145002150rxnav_historical
00145002161rxnav_historical
17630001000rxnav_historical
17630001001rxnav_historical
17630001002rxnav_historical
17630001005rxnav_historical_indirect
35356023100rxnav_historical
40076002100rxnav_historical
40076002150rxnav_historical
54868542400rxnav_historical
63032002100rxnav_historical
63032002101rxnav_historical
63032002112rxnav_historical_indirect
63032002115rxnav_historical_indirect
63032002150rxnav_historical
63094234501rxnav_historical
63094234505rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
4a7c165f-034f-431a-a210-b5973fda9f10Mylan Pharmaceuticals Inc.20180430
51fe8c40-5e56-4449-8995-f227c8bb5a50Luxíq ® (betamethasonevalerate) Foam, 0.12%Prestium Pharma, Inc.20140529
8afe91fe-563c-4d51-b826-ec78b92575beNational Council for Prescription Drug Programs20130213
c781c263-f071-4f1c-ac3a-c8c3a28c1874National Council for Prescription Drug Programs20130213
7698a8ad-d7a5-41ae-b58a-d50a60bb0b76National Council for Prescription Drug Programs20120724
910cd7fe-abe1-4fca-bf70-0a0c5e6b3fd7National Council for Prescription Drug Programs20120724
d2fd0bd1-72db-4cbf-846f-b92115e499d7National Council for Prescription Drug Programs20120724
3dab9411-df12-4073-9cc1-3273e2aee7e7Luxíq ® (betamethasone valerate) Foam, 0.12%Physicians Total Care, Inc.20100629

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC05AACorticosteroidsATC1-4betamethasone
ATCS03BACorticosteroidsATC1-4betamethasone
ATCS02BACorticosteroidsATC1-4betamethasone
ATCR01ADCorticosteroidsATC1-4betamethasone
ATCA07EACorticosteroids acting locallyATC1-4betamethasone
ATCS01BACorticosteroids, plainATC1-4betamethasone
ATCD07ACCorticosteroids, potent (group III)ATC1-4betamethasone
ATCD07XCCorticosteroids, potent, other combinationsATC1-4betamethasone
ATCS01CBCorticosteroids/antiinfectives/mydriatics in combinationATC1-4betamethasone
ATCR03BAGlucocorticoidsATC1-4betamethasone
ATCH02ABGlucocorticoidsATC1-4betamethasone
FDASPLN0000175576CorticosteroidEPChas_epcbetamethasone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moabetamethasone
MEDRTD001623BetamethasoneCHEMhas_ingredientbetamethasone
MEDRTD001624Betamethasone ValerateCHEMhas_ingredientbetamethasone valerate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatbetamethasone valerate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatbetamethasone
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatbetamethasone valerate
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatbetamethasone
MEDRTD004342Drug HypersensitivityDISEASEci_withbetamethasone
MEDRTD004342Drug HypersensitivityDISEASEci_withbetamethasone valerate
MEDRTD005148Facial DermatosesDISEASEmay_treatbetamethasone
MEDRTD005148Facial DermatosesDISEASEmay_treatbetamethasone valerate
MEDRTD005533Foot DermatosesDISEASEmay_treatbetamethasone
MEDRTD005533Foot DermatosesDISEASEmay_treatbetamethasone valerate
MEDRTD006229Hand DermatosesDISEASEmay_treatbetamethasone
MEDRTD006229Hand DermatosesDISEASEmay_treatbetamethasone valerate
MEDRTD007249InflammationDISEASEmay_treatbetamethasone valerate
MEDRTD007249InflammationDISEASEmay_treatbetamethasone
MEDRTD007868Leg DermatosesDISEASEmay_treatbetamethasone valerate
MEDRTD007868Leg DermatosesDISEASEmay_treatbetamethasone
MEDRTD009181MycosesDISEASEci_withbetamethasone valerate
MEDRTD009181MycosesDISEASEci_withbetamethasone
MEDRTD011538Pruritus AniDISEASEmay_treatbetamethasone valerate
MEDRTD011538Pruritus AniDISEASEmay_treatbetamethasone
MEDRTD011565PsoriasisDISEASEmay_treatbetamethasone valerate
MEDRTD011565PsoriasisDISEASEmay_treatbetamethasone
MEDRTD016553Purpura, Thrombocytopenic, IdiopathicDISEASEci_withbetamethasone valerate
MEDRTD016553Purpura, Thrombocytopenic, IdiopathicDISEASEci_withbetamethasone
MEDRTD012536Scalp DermatosesDISEASEmay_treatbetamethasone
MEDRTD012536Scalp DermatosesDISEASEmay_treatbetamethasone valerate
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moabetamethasone valerate
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moabetamethasone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moabetamethasone valerate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moabetamethasone
MEDRTN0000008297Antipruritic ActivityPEhas_pebetamethasone valerate
MEDRTN0000008297Antipruritic ActivityPEhas_pebetamethasone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pebetamethasone valerate
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pebetamethasone
MEDRTN0000009928Decreased Cellular MigrationPEhas_pebetamethasone valerate
MEDRTN0000009928Decreased Cellular MigrationPEhas_pebetamethasone
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pebetamethasone
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pebetamethasone valerate
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pebetamethasone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pebetamethasone valerate
MEDRTN0000008700Decreased Lysosomal FunctionPEhas_pebetamethasone
MEDRTN0000008700Decreased Lysosomal FunctionPEhas_pebetamethasone valerate
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pebetamethasone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pebetamethasone valerate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pebetamethasone
MEDRTN0000008841Decreased Protein SynthesisPEhas_pebetamethasone valerate
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pebetamethasone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pebetamethasone valerate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pebetamethasone valerate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pebetamethasone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH1.2 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable SynonymLuxiq 0.12 % Topical Foam
SOURCESSourceGold Standard Alchemy